ArticleCost effectiveness and resource allocation : C/E2026
Cost-effectiveness and return on investment of 20-valent pneumococcal conjugate vaccine use among adults in England: analysis from the societal perspective.
Diana Mendes et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.